Cargando…

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer

Ovarian cancer is the deadliest of all gynecologic cancers. Despite success with initial chemotherapy, the majority of patients relapse with an incurable disease. Development of chemotherapy resistance is a major factor for poor long-term survival in ovarian cancer. The biological effects of estroge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Zhou, Mei, Nair, Binoj C., Kost, Edward, Tekmal, Rajeshwar Rao, Li, Rong, Rao, Manjeet K., Curiel, Tyler, Vadlamudi, Ratna K., Sareddy, Gangadhara R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564823/ https://www.ncbi.nlm.nih.gov/pubmed/28654894 http://dx.doi.org/10.18632/oncotarget.18442

Ejemplares similares

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways
por: Zhou, Mei, et al.
Publicado: (2019)

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
por: He, Yi, et al.
Publicado: (2022)

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2019)

Brain-Derived Estrogen and Neurological Disorders
por: Brann, Darrell W., et al.
Publicado: (2022)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Neuron-Derived Estrogen—A Key Neuromodulator in Synaptic Function and Memory
por: Brann, Darrell W., et al.
Publicado: (2021)

Brain-derived estrogen and neural function
por: Brann, Darrell W., et al.
Publicado: (2022)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain
por: Lu, Yujiao, et al.
Publicado: (2020)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
por: Liu, Zexuan, et al.
Publicado: (2022)

Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice
por: Wang, Jing, et al.
Publicado: (2023)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

2114: The role of estrogen receptor-β in the development of the early endometriotic lesion
por: Knudtson, Jennifer, et al.
Publicado: (2018)

Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory
por: Lu, Yujiao, et al.
Publicado: (2019)

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
por: Liu, Junhao, et al.
Publicado: (2021)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
por: Roy, Sudipa Saha, et al.
Publicado: (2013)

KDM1 is a novel therapeutic target for the treatment of gliomas
por: Sareddy, Gangadhara R., et al.
Publicado: (2012)

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
por: Gupta, Harshita B, et al.
Publicado: (2016)

Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
por: Liu, Xihui, et al.
Publicado: (2022)

NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol
por: Thakkar, Roshni, et al.
Publicado: (2016)

301 Inhibition of lysine-specific histone demethylase 1A (KDM1A/LSD1) attenuates DNA double strand break repair and enhances efficacy of temozolomide in glioblastoma
por: Alejo, Salvador, et al.
Publicado: (2023)

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
por: Saha Roy, Sudipa, et al.
Publicado: (2012)

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway
por: Bowers, Laura W., et al.
Publicado: (2015)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

Cross-talk between miR-471-5p and autophagy component proteins regulates LC3-associated phagocytosis (LAP) of apoptotic germ cells
por: Panneerdoss, Subbarayalu, et al.
Publicado: (2017)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Regulation and Role of Neuron-Derived Hemoglobin in the Mouse Hippocampus
por: Lu, Yujiao, et al.
Publicado: (2022)

Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer
por: Yuan, Bin, et al.
Publicado: (2016)

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling
por: Yue, Xuetian, et al.
Publicado: (2020)

Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells
por: Mukhopadhyay, Keya De, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gh345i21kdji7a8hh8cmqva30o